Trasis offers end-to-end CDMO services, covering the complete development and manufacturing journey from the chemical synthesis of small molecules and peptides to the production of ready-to-use sterile drug solutions.
Early Process Development & Scale-Up
- Scalable API and precursor synthesis, from R&D to commercial production
- Raw material sourcing and cGMP assessment
- Polymorph screening, impurity profiling, and stability studies
- Process analytics and regulatory (CMC) support
Industrialization & Validation
- Analytical standards
- Analytical method development and validation
- Chiral separations and compound purification
- IND and DMF documentation support and submission
- EU QP release support
Intermediate & API Manufacturing
- Preclinical batch production and clinical trial supply
- Industrial-scale manufacturing of APIs, precursors, and intermediates
- Technology transfer and scale-up for commercial production
- GMP and non-GMP manufacturing facilities
Formulation & Sterile Fill & Finish
- Aseptic processing and customized formulations
- Manufacturing of small molecules, peptides, macrocycles, chelators, and inorganic and organic salts
- Cold kits
- Kits for bioconjugation